Search Results

There are 18161 results for: content related to: Molecular determinants of FGF-21 activity—synergy and cross-talk with PPARγ signaling

  1. Rosiglitazone for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christine Clar and Susanne H Ebrahim

    Published Online : 18 JUL 2007, DOI: 10.1002/14651858.CD006063.pub2

  2. You have free access to this content
    Adiponectin fine-tuning of liver regeneration dynamics revealed through cellular network modelling

    The Journal of Physiology

    Volume 593, Issue 2, 15 January 2015, Pages: 365–383, Jason M. Correnti, Daniel Cook, Edita Aksamitiene, Aditi Swarup, Babatunde Ogunnaike, Rajanikanth Vadigepalli and Jan B. Hoek

    Version of Record online : 15 JAN 2015, DOI: 10.1113/jphysiol.2014.284109

  3. Thiazolidinediones as PPAR Agonists

    Standard Article

    International Textbook of Diabetes Mellitus

    Sunder Mudaliar and Robert R. Henry

    Published Online : 15 MAR 2004, DOI: 10.1002/0470862092.d0611

  4. Nuclear Hormone Receptor Medicinal Chemistry

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Peter T.W. Cheng, Ellen Kick and Ranjan Mukherjee

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc191

  5. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction



    Version of Record online : 8 JAN 2009, DOI: 10.1111/j.1440-1797.2008.01032.x

  6. Regulation of adipose triglyceride lipase by rosiglitazone

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 2, February 2009, Pages: 131–142, L.-F. Liu, A. Purushotham, A. A. Wendel, K. Koba, J. DeIuliis, K Lee and M. A. Belury

    Version of Record online : 17 JUL 2008, DOI: 10.1111/j.1463-1326.2008.00916.x

  7. You have free access to this content
    Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone

    Journal of Neurochemistry

    Volume 97, Issue 2, April 2006, Pages: 435–448, Yumin Luo, Wei Yin, Armando P. Signore, Feng Zhang, Zhen Hong, Suping Wang, Steven H. Graham and Jun Chen

    Version of Record online : 15 MAR 2006, DOI: 10.1111/j.1471-4159.2006.03758.x

  8. Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update

    Fundamental & Clinical Pharmacology

    Volume 22, Issue 3, June 2008, Pages: 247–264, Pantelis A. Sarafidis

    Version of Record online : 15 APR 2008, DOI: 10.1111/j.1472-8206.2008.00568.x

  9. FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists

    Journal of Bone and Mineral Research

    Volume 32, Issue 4, April 2017, Pages: 834–845, Xiaodong Li, Shanaka Stanislaus, Frank Asuncion, Qing-Tian Niu, Narumol Chinookoswong, Kelly Villasenor, Jin Wang, Philip Wong, Rogely Boyce, Denise Dwyer, Chun-Ya Han, Michelle M Chen, Benxian Liu, Marina Stolina, Hua Zhu Ke, Michael S Ominsky, Murielle M Véniant and Jing Xu

    Version of Record online : 9 SEP 2016, DOI: 10.1002/jbmr.2936

  10. You have free access to this content
    ASBMR 31st Annual Meeting SA0001–SA0464

    Journal of Bone and Mineral Research

    Volume 24, Issue S1, 2009, Pages: S150–S236,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650241303

  11. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone

    Clinical Pharmacology & Therapeutics

    Volume 76, Issue 3, September 2004, Pages: 239–249, Mikko Niemi, Janne T. Backman and Pertti J. Neuvonen

    Version of Record online : 4 SEP 2004, DOI: 10.1016/j.clpt.2004.05.001

  12. You have free access to this content
    Rosiglitazone selectively inhibits KATP channels by acting on the KIR6 subunit

    British Journal of Pharmacology

    Volume 167, Issue 1, September 2012, Pages: 26–36, Lei Yu, Xin Jin, Ningren Cui, Yang Wu, Zhenda Shi, Daling Zhu and Chun Jiang

    Version of Record online : 3 AUG 2012, DOI: 10.1111/j.1476-5381.2012.01934.x

  13. PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells

    Journal of Cellular Biochemistry

    Volume 118, Issue 1, January 2017, Pages: 163–171, Micaela Morgado and Daniel D. Carson

    Version of Record online : 24 JUN 2016, DOI: 10.1002/jcb.25622

  14. You have free access to this content
    Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo

    International Journal of Cancer

    Volume 122, Issue 12, 15 June 2008, Pages: 2858–2863, Yun Dai, Liang Qiao, Kwok Wah Chan, Bing Zou, Juan Ma, Hui Y. Lan, Qing Gu, Zesong Li, Yan Wang, Benny L.W. Wong and Benjamin C.Y. Wong

    Version of Record online : 19 MAR 2008, DOI: 10.1002/ijc.23443

  15. You have free access to this content
    ASBMR 2010 Annual Meeting 1001–1264

    Journal of Bone and Mineral Research

    Volume 25, Issue S1, 2010, Pages: S1–S81,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650251301

  16. Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs

    Veterinary and Comparative Oncology

    Volume 12, Issue 1, March 2014, Pages: 1–9, S. Allstadt Frazier, D. S. McKemie, T. A. Guerrero, H. LaChapelle, K. A. Skorupski, P. H. Kass and C. O. Rodriguez Jr

    Version of Record online : 24 FEB 2012, DOI: 10.1111/j.1476-5829.2012.00322.x

  17. You have free access to this content
    Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation

    British Journal of Pharmacology

    Volume 163, Issue 3, June 2011, Pages: 510–520, I Jeong, BH Choi and SJ Hahn

    Version of Record online : 11 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01210.x

  18. FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho

    Journal of Cellular Physiology

    Volume 215, Issue 1, April 2008, Pages: 1–7, Alexei Kharitonenkov, James D. Dunbar, Holly A. Bina, Stuart Bright, Julie S. Moyers, Chen Zhang, Liyun Ding, Radmila Micanovic, Sean F. Mehrbod, Michael D. Knierman, John E. Hale, Tamer Coskun and Armen B. Shanafelt

    Version of Record online : 6 DEC 2007, DOI: 10.1002/jcp.21357

  19. You have free access to this content
    Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline

    British Journal of Pharmacology

    Volume 164, Issue 8, December 2011, Pages: 2064–2072, Lei Yu, Xin Jin, Yang Yang, Ningren Cui and Chun Jiang

    Version of Record online : 21 NOV 2011, DOI: 10.1111/j.1476-5381.2011.01539.x

  20. Rosiglitazone and PPAR-γ overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins

    Journal of Cellular Physiology

    Volume 220, Issue 1, July 2009, Pages: 58–71, Jui-Sheng Wu, Teng-Nan Lin and Kenneth K. Wu

    Version of Record online : 19 FEB 2009, DOI: 10.1002/jcp.21730